Buchmann I - Search Results

1

[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].

Buchmann I, Guhlmann CA, Elsner K, Gfrörer W, Schirrmeister H, Kotzerke J, Buck A, Reske SN. Buchmann I, et al. Nuklearmedizin. 1999;38(8):319-22. Nuklearmedizin. 1999. PMID: 10615665 German.

2

[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.

Buchmann I, Vogg AT, Glatting G, Schultheiss S, Möller P, Leithäuser F, Schulte M, Gfrörer W, Kotzerke J, Reske SN. Buchmann I, et al. Cancer Biother Radiopharm. 2003 Jun;18(3):327-37. doi: 10.1089/108497803322285080. Cancer Biother Radiopharm. 2003. PMID: 12954120

3

FDG PET for imaging pericardial manifestations of Hodgkin lymphoma.

Buchmann I, Wandt H, Wahl A, Reske SN. Buchmann I, et al. Clin Nucl Med. 2003 Sep;28(9):760-1. doi: 10.1097/01.rlu.0000082666.85547.94. Clin Nucl Med. 2003. PMID: 12973000

4

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease.

Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, Elsner K, Frickhofen N, Reske SN, Bergmann L. Bangerter M, et al. Among authors: buchmann i. Ann Oncol. 1998 Oct;9(10):1117-22. doi: 10.1023/a:1008486928190. Ann Oncol. 1998. PMID: 9834825 Free article.

5

Positron emission tomography for detection and staging of malignant lymphoma.

Buchmann I, Moog F, Schirrmeister H, Reske SN. Buchmann I, et al. Recent Results Cancer Res. 2000;156:78-89. doi: 10.1007/978-3-642-57054-4_10. Recent Results Cancer Res. 2000. PMID: 10802866

6

Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.

Klose T, Leidl R, Buchmann I, Brambs HJ, Reske SN. Klose T, et al. Among authors: buchmann i. Eur J Nucl Med. 2000 Oct;27(10):1457-64. doi: 10.1007/s002590000323. Eur J Nucl Med. 2000. PMID: 11083533

7

Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?

Buck AC, Schirrmeister HH, Guhlmann CA, Diederichs CG, Shen C, Buchmann I, Kotzerke J, Birk D, Mattfeldt T, Reske SN. Buck AC, et al. Among authors: buchmann i. J Nucl Med. 2001 May;42(5):721-5. J Nucl Med. 2001. PMID: 11337566 Free article.

8

2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.

Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN. Buchmann I, et al. Cancer. 2001 Mar 1;91(5):889-99. Cancer. 2001. PMID: 11251940 Clinical Trial.

9

Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation.

Reske SN, Bunjes D, Buchmann I, Seitz U, Glatting G, Neumaier B, Kotzerke J, Buck A, Martin H, Döhner H, Bergmann L. Reske SN, et al. Among authors: buchmann i. Eur J Nucl Med. 2001 Jul;28(7):807-15. doi: 10.1007/s002590100544. Eur J Nucl Med. 2001. PMID: 11504076 Clinical Trial.

10

Novel imaging techniques in NHL: clinical results with PET imaging.

Buchmann I, Reske SN. Buchmann I, et al. Ann Hematol. 2001;80 Suppl 3:B54-7. doi: 10.1007/pl00022791. Ann Hematol. 2001. PMID: 11757709 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters